Bremelanotide is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone and a selective melanocortin receptor agonist indicated for the treatment of generalized, acquired hypoactive sexual… Read more
Bremelanotide is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone and a selective melanocortin receptor agonist indicated for the treatment of generalized, acquired hypoactive sexual desire disorder (HSDD) in premenopausal women. As a cyclic heptapeptide, this agent works by activating melanocortin receptors in the central nervous system to modulate sexual desire. The compounds in this category, including Bremelanotide reference standards, impurity profiling materials, and stable isotope-labelled analogues, are essential for rigorous pharmaceutical analysis. Analytical laboratories utilize these high-quality standards to support impurity identification, method validation, and the development of robust quality control protocols for both the active pharmaceutical ingredient and finished dosage forms. By providing accurately characterized reference materials, this collection facilitates precise quantitative and qualitative assessments in compliance with stringent regulatory standards for peptide drug monitoring and impurity evaluation throughout the product lifecycle.